Menu Back to 21-Successful-Drug-Development-Best-Practices-for-Drug-Development-Planning-Agency-Interactions-and-Regulatory-Document-Writing
DIA 2017

DIA 2017 is located at:

McCormick Place
Gate 4
2301 South Martin Luther King Jr. Drive
Chicago, IL


Understanding best practices is critical as you design a clinical program and regulatory strategy for a drug or biologic product. Identifying and obtaining the data actually needed for a product development program is key to the success of the program. Thinking ahead to the marketing application helps a sponsor avoid many of the common mistakes that are made in overall drug development programs. Even though it may be years before an NDA/BLA/MAA submission, the marketing application is the goal of each development program and should be kept in view throughout the program to avoid pitfalls and delays in submission and product approval.

This short course will cover common mistakes and solutions in the areas of drug development planning, regulatory agency interactions, and regulatory document writing. Practical advice for each of these areas will be presented, with an emphasis on learning from past examples that illustrate approaches to adopt or to avoid.


Who should attend?

This short course is designed for professionals with basic knowledge in regulatory affairs, agency submissions, and regulatory medical writing.

Learning objectives

At the conclusion of this course, participants should be able to:

  • Identify ways to increase the efficiency and success of product development programs
  • Describe key principles for successful regulatory interactions during drug development and marketing application preparation
  • Discuss best practices in developing successful clinical trial designs, statistical analysis plans, and regulatory submission documents

Contact us

Registration Questions?

Send Email